Silk Road Medical Stock Today
SILK Stock | USD 17.71 0.34 1.88% |
Performance11 of 100
| Odds Of DistressLess than 31
|
Silk Road is selling for 17.71 as of the 17th of April 2024. This is a -1.88 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 17.58. Silk Road has about a 31 percent probability of financial distress in the next few years of operation but had a somewhat good performance during the last 90 days. Equity ratings for Silk Road Medical are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 18th of March 2024 and ending today, the 17th of April 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 4th of April 2019 | Category Healthcare | Classification Health Care |
Silk Road Medical, Inc. operates as a medical device company in the United States. The company was incorporated in 2007 and is headquartered in Sunnyvale, California. Silk Road operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. The company has 39.17 M outstanding shares of which 4.09 M shares are at this time shorted by private and institutional investors with about 4.25 trading days to cover. More on Silk Road Medical
Moving together with Silk Stock
0.72 | DVA | DaVita HealthCare Financial Report 13th of May 2024 | PairCorr |
Moving against Silk Stock
0.78 | XRAY | Dentsply Sirona Financial Report 1st of May 2024 | PairCorr |
0.71 | INNV | InnovAge Holding Corp Financial Report 14th of May 2024 | PairCorr |
0.7 | LUCY | Innovative Eyewear | PairCorr |
0.56 | ACHC | Acadia Healthcare Earnings Call This Week | PairCorr |
0.55 | AGL | agilon health Financial Report 14th of May 2024 | PairCorr |
0.54 | FIGS | Figs Inc Financial Report 2nd of May 2024 | PairCorr |
0.52 | MBOT | Microbot Medical Financial Report 15th of May 2024 | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 14th of May 2024
Silk Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Silk Road's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Silk Road or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
President CEO, Director | Erica Rogers | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Health Care, NASDAQ Composite, Karachi All Share, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Average Analyst Recommendation Analysts covering Silk Road report their recommendations after researching Silk Road's financial statements, talking to executives and customers, or listening in on Silk Road's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Silk Road Medical. The Silk consensus assessment is calculated by taking the average forecast from all of the analysts covering Silk Road. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength Based on the measurements of operating efficiency obtained from Silk Road's historical financial statements, Silk Road Medical is not in a good financial situation at this time. It has a very high probability of going through financial hardship in May. Financial strength of Silk Road Medical is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Silk Road's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Silk Road's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Silk Road's financial leverage. It provides some insight into what part of Silk Road's total assets is financed by creditors.
|
Silk Road Medical (SILK) is traded on NASDAQ Exchange in USA. It is located in 1213 Innsbruck Drive, Sunnyvale, CA, United States, 94089 and employs 474 people. Silk Road is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 693.78 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Silk Road's market, we take the total number of its shares issued and multiply it by Silk Road's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Silk Road Medical conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 39.17 M outstanding shares of which 4.09 M shares are at this time shorted by private and institutional investors with about 4.25 trading days to cover.
Silk Road Medical currently holds about 108.87 M in cash with (32.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.09.
Check Silk Road Probability Of Bankruptcy
Ownership AllocationSilk Road maintains a total of 39.17 Million outstanding shares. The majority of Silk Road Medical outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Silk Road to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Silk Road Medical. Please pay attention to any change in the institutional holdings of Silk Road Medical as this could imply that something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Silk Ownership Details
Silk Stock Price Odds Analysis
Proceeding from a normal probability distribution, the odds of Silk Road jumping above the current price in 90 days from now is about 24.38%. The Silk Road Medical probability density function shows the probability of Silk Road stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 2.1313. This usually implies as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Silk Road will likely underperform. Additionally, silk Road Medical has an alpha of 0.3735, implying that it can generate a 0.37 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Silk Road to move above the current price in 90 days from now is about 24.38 (This Silk Road Medical probability density function shows the probability of Silk Stock to fall within a particular range of prices over 90 days) .
Silk Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Silk Road that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Silk Road's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Silk Road's value.Instituion | Recorded On | Shares | |
Bamco Inc | 2023-12-31 | 1.2 M | |
Adage Capital Partners Gp Llc | 2023-12-31 | 1000 K | |
Geode Capital Management, Llc | 2023-12-31 | 860.3 K | |
Rings Capital Management Llc | 2023-12-31 | 860 K | |
Arrowmark Colorado Holdings, Llc (arrowmark Partners) | 2023-12-31 | 823.1 K | |
Two Sigma Advisers, Llc | 2023-12-31 | 657.4 K | |
Citadel Advisors Llc | 2023-09-30 | 618.1 K | |
Two Sigma Investments Llc | 2023-12-31 | 587.8 K | |
Parkman Healthcare Partners Llc | 2023-12-31 | 545.2 K | |
Wasatch Advisors Inc. | 2023-12-31 | 4 M | |
Goldman Sachs Group Inc | 2023-12-31 | 4 M |
Silk Road Historical Income Statement
Silk Road Medical Income Statement is one of the three primary financial statements used for reporting Silk's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Silk Road Medical revenue and expense. Silk Road Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Silk Road's Net Interest Income is quite stable compared to the past year. Interest Income is expected to rise to about 10.5 M this year, although the value of Total Revenue will most likely fall to about 95 M. View More FundamentalsSilk Stock Against Markets
Picking the right benchmark for Silk Road stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Silk Road stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Silk Road is critical whether you are bullish or bearish towards Silk Road Medical at a given time. Please also check how Silk Road's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Silk Road without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Dashboard Now
Portfolio DashboardPortfolio dashboard that provides centralized access to all your investments |
All Next | Launch Module |
Silk Road Corporate Management
Elected by the shareholders, the Silk Road's board of directors comprises two types of representatives: Silk Road inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Silk. The board's role is to monitor Silk Road's management team and ensure that shareholders' interests are well served. Silk Road's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Silk Road's outside directors are responsible for providing unbiased perspectives on the board's policies.
Kevin Klemz | Chief EVP | Profile | |
Sumaira Macdonald | Chief Medical Officer | Profile | |
Mhairi Jones | VP Accounting | Profile | |
Kevin Ballinger | Chief Sec | Profile | |
Tammy Leitsinger | Compliance Affairs | Profile |
How to buy Silk Stock?
Before investing in Silk Road, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Silk Road. To buy Silk Road stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Silk Road. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Silk Road stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Silk Road Medical stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Silk Road Medical stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Silk Road Medical, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Silk Stock please use our How to Invest in Silk Road guide.
Already Invested in Silk Road Medical?
The danger of trading Silk Road Medical is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Silk Road is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Silk Road. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Silk Road Medical is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Silk Road Medical is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Silk Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Silk Road Medical Stock. Highlighted below are key reports to facilitate an investment decision about Silk Road Medical Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Silk Road Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Complementary Tools for Silk Stock analysis
When running Silk Road's price analysis, check to measure Silk Road's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Silk Road is operating at the current time. Most of Silk Road's value examination focuses on studying past and present price action to predict the probability of Silk Road's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Silk Road's price. Additionally, you may evaluate how the addition of Silk Road to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |
Is Silk Road's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Silk Road. If investors know Silk will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Silk Road listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.44) | Revenue Per Share 4.565 | Quarterly Revenue Growth 0.18 | Return On Assets (0.14) | Return On Equity (0.35) |
The market value of Silk Road Medical is measured differently than its book value, which is the value of Silk that is recorded on the company's balance sheet. Investors also form their own opinion of Silk Road's value that differs from its market value or its book value, called intrinsic value, which is Silk Road's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Silk Road's market value can be influenced by many factors that don't directly affect Silk Road's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Silk Road's value and its price as these two are different measures arrived at by different means. Investors typically determine if Silk Road is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Silk Road's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.